NIVASOREXANT

UNII:	0N15II81VX
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₃H₂₃N₇O₂
Preferred Substance Name:	NIVASOREXANT
InChIKey:	GKPHAIOJCHBZCT-HXUWFJFHSA-N
GSRS Full Record:	0N15II81VX i

1435480-40-2
(4-Methyl-2-[1,2,3]triazol-2-ylphenyl)-[(R)-3-(3-[1,2,3]triazol-2-ylbenzyl)-morpholin-4-yl]-methanone
(4³R)-6⁴-methyl-4(3,4)-morpholina-1,7(2)-di[1,2,3]triazola-2(1,3),6(1,2)-dibenzenaheptaphan-5-one
Methanone, [4-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl][(3R)-3-[[3-(2H-1,2,3-triazol-2-yl)phenyl]methyl]-4-morpholinyl]-
Nivasorexant
Nivasorexant [WHO-DD]
[4-methyl-2-(triazol-2-yl)phenyl]-[(3R)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone
[4-methyl-2-(triazol-2-yl)phenyl]-[(3R)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone
nivasorexant [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

NIVASOREXANT

Synonyms and Mappings

Resources